Biomarkers and biosensors for the early diagnosis of lung cancer

[1]  P. J. Pretorius,et al.  Is the role of circulating DNA as a biomarker of cancer being prematurely overrated? , 2010, Clinical biochemistry.

[2]  Polymorphisms in the survivin gene and the risk of lung cancer. , 2008, Lung cancer.

[3]  J. Mancini,et al.  Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer. , 2004, Respiratory medicine.

[4]  K. Østerlind,et al.  Chromogranin A, a significant prognostic factor in small cell lung cancer , 1999, British Journal of Cancer.

[5]  Marek Piliarik,et al.  Label-free detection of cancer biomarker candidates using surface plasmon resonance imaging , 2009, Analytical and bioanalytical chemistry.

[6]  E. Lemarié,et al.  KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer. , 2005, Biochemical and biophysical research communications.

[7]  J. Rusling,et al.  A microfluidic electrochemiluminescent device for detecting cancer biomarker proteins , 2013, Analytical and Bioanalytical Chemistry.

[8]  J. Herman,et al.  Predicting lung cancer by detecting aberrant promoter methylation in sputum. , 2000, Cancer research.

[9]  Mohammad S Noor,et al.  ナノチューブの成長,整列,キラリティおよび特性における触媒液滴の双極子モーメントの可能な役割 , 2012 .

[10]  T. Mitsudomi,et al.  Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  Z. Altintas,et al.  DNA-based biosensor platforms for the detection of TP53 mutation , 2012 .

[12]  J. Vaqué,et al.  Ultrasensitive electrochemical immunosensor for oral cancer biomarker IL-6 using carbon nanotube forest electrodes and multilabel amplification. , 2010, Analytical chemistry.

[13]  S. Petersen,et al.  Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer. , 2001, European journal of cancer.

[14]  S. Hanash,et al.  Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera. , 2009, Biosensors & bioelectronics.

[15]  J. Homola.  Present and future of surface plasmon resonance biosensors , 2003, Analytical and bioanalytical chemistry.

[16]  B. Shapiro,et al.  Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease , 1983, Cancer.

[17]  H. Harn,et al.  Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  U. Pastorino,et al.  Detecting lung cancer in plasma with the use of multiple genetic markers , 2004, International journal of cancer.

[19]  David Shitrit,et al.  Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. , 2005, The oncologist.

[20]  M. Ohta,et al.  Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. , 2002, The Annals of thoracic surgery.

[21]  R. Hruban,et al.  Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. , 1994, Cancer research.

[22]  M. Mascini,et al.  Biosensors for Clinical Biomarkers , 2012 .

[23]  D. Preston,et al.  Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. , 1991, Radiation research.

[24]  Zhanfang Ma,et al.  Electrochemical immunosensor for simultaneous detection of multiplex cancer biomarkers based on graphene nanocomposites. , 2013, Biosensors & bioelectronics.

[25]  I. Watt,et al.  Laparoscopy, ultrasound and computed tomography in cancer of the oesophagus and gastric cardia: A prospective comparison for detecting intra‐abdominal metastases , 1989, The British journal of surgery.

[26]  James F Rusling,et al.  Multiplexed electrochemical protein detection and translation to personalized cancer diagnostics. , 2013, Analytical chemistry.

[27]  M. Taya,et al.  Detection of Carcinoembryonic Antigens Using a Surface Plasmon Resonance Biosensor , 2008, Sensors.

[28]  W. Carney.  Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers , 2007, Expert review of molecular diagnostics.

[29]  Maëlle Perfézou,et al.  Cancer detection using nanoparticle-based sensors. , 2012, Chemical Society reviews.

[30]  L. Anderson,et al.  DNA damage, superoxide, and mutant K-ras in human lung adenocarcinoma cells. , 2007, Free radical biology & medicine.

[31]  M. Stroun,et al.  Neoplastic characteristics of the DNA found in the plasma of cancer patients. , 1989, Oncology.

[32]  W. Wąsowicz,et al.  Expression of selenoprotein-coding genes SEPP1, SEP15 and hGPX1 in non-small cell lung cancer. , 2009, Lung cancer.

[33]  A R Padhani,et al.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.

[34]  R. Corn,et al.  Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging. , 2007, Analytical chemistry.

[35]  David Elashoff,et al.  Electrochemical Sensor for Multiplex Biomarkers Detection , 2009, Clinical Cancer Research.

[36]  Valeri Vasioukhin,et al.  Point mutations of the N‐ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia , 1994, British journal of haematology.

[37]  K. Hamamoto,et al.  Serum CA125 level is a good prognostic indicator in lung cancer. , 1990, British Journal of Cancer.

[38]  M. Seemann,et al.  An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions. , 1999, Lung cancer.

[39]  E Chyczewska,et al.  K-ras codon 12 mutations may be detected in serum of patients suffering from adeno- and large cell lung carcinoma. A preliminary report. , 2001, Folia histochemica et cytobiologica.

[40]  J. Pyun,et al.  Additive assay of cancer marker CA 19-9 by SPR biosensor , 2006 .

[41]  Diethelm Johannsmann,et al.  High frequency tribological investigations on quartz resonator surfaces , 1999 .

[42]  T. Kuriyama,et al.  Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer. , 2001, Anticancer research.

[43]  Amy Berrington de González,et al.  Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries , 2004, The Lancet.

[44]  D. Gandara,et al.  Origin and prognostic value of circulating KRAS mutations in lung cancer patients. , 2007, Cancer letters.

[45]  James F Rusling,et al.  Nanomaterials-based electrochemical immunosensors for proteins. , 2012, Chemical record.

[46]  M E Raichle,et al.  Positron-emission tomography. , 1980, Scientific American.

[47]  P. Stieber,et al.  Apoptotic markers in cancer. , 2004, Clinical biochemistry.

[48]  Jonathan I. Epstein,et al.  Predicting Cancer Following a Diagnosis of High-Grade Prostatic Intraepithelial Neoplasia on Needle Biopsy: Data on Men With More Than One Follow-Up Biopsy , 2001, The American journal of surgical pathology.

[49]  M. Cazzola,et al.  Biomarkers of lung damage associated with tobacco smoke in induced sputum. , 2009, Respiratory medicine.

[50]  Gen Tamura,et al.  Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. , 2007, Lung cancer.

[51]  N. Morgan,et al.  Electrochemical immunosensors for detection of cancer protein biomarkers. , 2012, ACS nano.

[52]  Hong Peng,et al.  Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. , 2010, Lung cancer.

[53]  Luca Benini,et al.  Label-free cancer markers detection by capacitance biochip , 2009 .

[54]  James F. Rusling,et al.  Nanoscience-Based Electrochemical Sensors and Arrays for Detection of Cancer Biomarker Proteins , 2013 .

[55]  A. Gajra,et al.  The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer. , 2002, Lung cancer.

[56]  H. Kawaguchi,et al.  Detection of a K-ras point mutation employing peptide nucleic acid at the surface of a SPR biosensor , 2003 .

[57]  V A Memoli,et al.  Soluble normal and mutated DNA sequences from single-copy genes in human blood. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[58]  K. Ino,et al.  Real-time monitoring biomarker expression of carcinoma cells by surface plasmon resonance biosensors. , 2012, Chemical communications.

[59]  Frank D Gilliland,et al.  Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma. , 2004, Carcinogenesis.

[60]  D. Sinton,et al.  Quantification of ovarian cancer markers with integrated microfluidic concentration gradient and imaging nanohole surface plasmon resonance. , 2013, The Analyst.

[61]  I. Tothill.  Biosensors for cancer markers diagnosis. , 2009, Seminars in cell & developmental biology.

[62]  M. Spitz,et al.  Telomere dysfunction: a potential cancer predisposition factor. , 2003, Journal of the National Cancer Institute.

[63]  Ling Li,et al.  Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients. , 2002, Cancer letters.

[64]  A. Hartmann,et al.  Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. , 2008, Human pathology.

[65]  Jianping Li,et al.  Electrochemical Biosensors for Cancer Biomarker Detection , 2012 .

[66]  R. Rosell,et al.  Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients. , 2010, Lung cancer.

[67]  Y. Sakao,et al.  Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[68]  I. Floriani,et al.  Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer , 2007, Cancer.

[69]  Noriyuki Misaki,et al.  Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[70]  M. Metintaş,et al.  Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions. , 2001, Lung cancer.

[71]  R. Rosell,et al.  Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer? , 2005, Lung cancer.

[72]  N. Viñolas,et al.  Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE , 2008, Tumor Biology.

[73]  Z. Altintas,et al.  Development of Surface Chemistry for SPR based Sensors for the Detection of Proteins and DNA molecules , 2012 .

[74]  P. Lamy,et al.  Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer. , 2000, Lung cancer.

[75]  Rashida Akter,et al.  Amplified electrochemical detection of a cancer biomarker by enhanced precipitation using horseradish peroxidase attached on carbon nanotubes. , 2012, Analytical chemistry.

[76]  Qing Lan,et al.  Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. , 2009, Lung cancer.

[77]  M. Tockman,et al.  Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer. , 2001, Lung cancer.

[78]  John K. Wiencke,et al.  p16INK4a and Histology-specific Methylation of CpG Islands by Exposure to Tobacco Smoke in Non-Small Cell Lung Cancer , 2001 .

[79]  Ning Xia,et al.  Simultaneous and label-free determination of wild-type and mutant p53 at a single surface plasmon resonance chip preimmobilized with consensus DNA and monoclonal antibody. , 2009, Analytical chemistry.

[80]  Dong Sun Kim,et al.  Polymorphisms in the Caspase7 gene and the risk of lung cancer. , 2009, Lung cancer.

[81]  B. Shapiro,et al.  Free DNA in the serum of cancer patients and the effect of therapy. , 1977, Cancer research.

[82]  U. Pastorino,et al.  Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer , 2003 .

[83]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[84]  Yasar Gurbuz,et al.  A novel magnetic particle-modified electrochemical sensor for immunosensor applications , 2012 .

[85]  Jin Man Kim,et al.  Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. , 2008, Cancer genetics and cytogenetics.

[86]  M. Paci,et al.  Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. , 2009, Lung cancer.

[87]  T. Oyama,et al.  Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma. , 2000, Anticancer Research.

[88]  T. Rauch,et al.  DNA methylation patterns in lung carcinomas. , 2009, Seminars in cancer biology.

[89]  Sanghamitra Chatterjee,et al.  Nanomaterials based electrochemical sensors for biomedical applications. , 2013, Chemical Society reviews.

[90]  Dan Du,et al.  Integrated lateral flow test strip with electrochemical sensor for quantification of phosphorylated cholinesterase: biomarker of exposure to organophosphorus agents. , 2012, Analytical chemistry.

[91]  A. Ardizzoni,et al.  Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers. , 2003, European journal of cancer.

[92]  Ying Zhuo,et al.  Simultaneous electrochemical immunoassay of three liver cancer biomarkers using distinguishable redox probes as signal tags and gold nanoparticles coated carbon nanotubes as signal enhancers. , 2012, Chemical communications.

[93]  Cristina Delerue-Matos,et al.  Molecular imprinted nanoelectrodes for ultra sensitive detection of ovarian cancer marker. , 2012, Biosensors & bioelectronics.

[94]  G. Cooper,et al.  Cellular transforming genes. , 1982, Science.

[95]  Waseem Asghar,et al.  Electrical detection of cancer biomarker using aptamers with nanogap break-junctions , 2012, Nanotechnology.

[96]  H. Sasaki,et al.  Expression of the cdc25B gene as a prognosis marker in non-small cell lung cancer. , 2001, Cancer letters.

[97]  Chien Chou,et al.  Diagnostic detection of human lung cancer-associated antigen using a gold nanoparticle-based electrochemical immunosensor. , 2010, Analytical chemistry.

[98]  Matthew A Cooper,et al.  A survey of the 2001 to 2005 quartz crystal microbalance biosensor literature: applications of acoustic physics to the analysis of biomolecular interactions , 2007, Journal of molecular recognition : JMR.

[99]  Shiu‐Ru Lin,et al.  A fast and convenient new technique to detect the therapeutic target, K-ras mutant, from peripheral blood in non-small cell lung cancer patients. , 2010, Lung Cancer.

[100]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[101]  Bradley P. Coe,et al.  Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features , 2008, Proceedings of the National Academy of Sciences.

[102]  M. Tsao,et al.  Clinical relevance of molecular markers in lung cancer. , 2002, Surgical oncology.

[103]  G. V. von Schulthess,et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.

[104]  A. Kessels,et al.  Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery , 2001, The Lancet.

[105]  James F Rusling,et al.  Ultrasensitive detection of cancer biomarkers in the clinic by use of a nanostructured microfluidic array. , 2012, Analytical chemistry.

[106]  Alexandre François,et al.  Multiplexing of radiative-surface plasmon resonance for the detection of gastric cancer biomarkers in a single optical fiber , 2013 .

[107]  Shaoyi Jiang,et al.  irect detection of carcinoembryonic antigen autoantibodies in clinical human erum samples using a surface plasmon resonance sensor on Ladda , 2009 .

[108]  E Gabrielson,et al.  Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[109]  Kazuya Kondo,et al.  The reduced expression and aberrant methylation of p16(INK4a) in chromate workers with lung cancer. , 2005, Lung cancer.

[110]  L. Woolner,et al.  Biopsy in cancer diagnosis. , 1951, The Surgical clinics of North America.

[111]  Yong Shin,et al.  Label-free DNA sensor for detection of bladder cancer biomarkers in urine , 2013 .

[112]  L. Mariani,et al.  Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. , 2001, Cancer research.

[113]  Ugo Pastorino,et al.  Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene. , 2007, Cancer letters.

[114]  Jing He,et al.  Electrochemical immunosensor with N-doped graphene-modified electrode for label-free detection of the breast cancer biomarker CA 15-3. , 2013, Biosensors & bioelectronics.

[115]  K. Wakasa,et al.  Serum Sialyl Lewisx and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer , 2007 .

[116]  J. Homola,et al.  Label-free biosensing in complex media: a referencing approach. , 2013, Analytical chemistry.

[117]  J. Downward.  Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[118]  Xin-chen Sun,et al.  Polymorphisms of the ribonucleotide reductase M1 gene and sensitivity to platin-based chemotherapy in non-small cell lung cancer. , 2009, Lung cancer.

[119]  J. Park,et al.  Telomere length and the risk of lung cancer , 2008, Cancer science.

[120]  Shaoyi Jiang,et al.  Use of a Surface Plasmon Resonance (SPR) Biosensor to Characterize Zwitterionic Coatings on SiO for Cancer Biomarker Detection , 2012 .

[121]  Jichang Wang,et al.  An electrochemical impedance sensor for the label-free ultrasensitive detection of interleukin-6 antigen , 2013 .

[122]  R. Aminov,et al.  Cytokine profile of Armenian patients with Familial Mediterranean fever. , 2008, Clinical biochemistry.

[123]  Yasar Gurbuz,et al.  A new microfluidics system with a hand-operated, on-chip actuator for immunosensor applications , 2012 .

[124]  Yasar Gurbuz,et al.  Surface plasmon resonance based immunosensor for the detection of the cancer biomarker carcinoembryonic antigen. , 2011, Talanta.

[125]  J. M. Ollinger,et al.  Positron Emission Tomography , 2018, Handbook of Small Animal Imaging.